Storia in 4 fonti

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

Ensitrelvir cut household contacts' risk of developing COVID by more than half

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo2 mesi fa

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

Ensitrelvir cut household contacts' risk of developing COVID by more than half

originale

healio.com2 mesi fa

FDA approves Xocova for COVID-19 prevention after exposure

The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to someone with the disease, according to the drug’s manufacturer, Shionogi.Xocova (ensitrelvir)…

Leggi questa versione → originale

Timeline cronologica

lunedì 1 giugno 2026·healio.com
FDA approves Xocova for COVID-19 prevention after exposure
The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to someone with the disease, according to the drug’s…
lunedì 1 giugno 2026·medpagetoday.com
FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure
Ensitrelvir cut household contacts' risk of developing COVID by more than half

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

Confronto fonti

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

FDA approves Xocova for COVID-19 prevention after exposure

Timeline cronologica

FDA approves Xocova for COVID-19 prevention after exposure

FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure

Shionogi wins US approval for first pill to prevent Covid following exposure

Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative

Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative

Shionogi wins US approval for first pill to prevent Covid following exposure